Differentially expressed genes in human peripheral blood as potential markers for statin response

Journal of Molecular Medicine

Volumn 90, Issue 2, 2012, Pages 201-211

  Won, Hong Hee ^a,b   Kim, Suk Ran ^c   Bang, Oh Young ^c   Lee, Sang Chol ^c   Huh, Wooseong ^a,c   Ko, Jae Wook ^a   Kim, Hyung Gun ^d   McLeod, Howard L ^e   O'Connell, Thomas M ^f   Kim, Jong Won ^c   Lee, Soo Youn ^a,c  

^a Samsung Medical Center   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Dankook University   (South Korea)

^e University of North Carolina   (United States)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Cholesterol; Gene array analysis; Gene expression; Pharmacogenomics; Statin

Indexed keywords

ATORVASTATIN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; CHOLESTEROL; EARLY GROWTH RESPONSE FACTOR 1; HLA DRB1 ANTIGEN; V SET DOMAIN CONTAINING T CELL ACTIVATION INHIBITOR 1;

ADULT; ANTIGEN BINDING; ARTICLE; BLOOD; BLOOD ANALYSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; FAMILIAL HYPERCHOLESTEROLEMIA; GENE EXPRESSION PROFILING; GENETIC MARKER; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MALE; SOUTH KOREA;

ADULT; BIOMARKERS, PHARMACOLOGICAL; CHOLESTEROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENES, MHC CLASS II; GENOME, HUMAN; HEPTANOIC ACIDS; HUMANS; HYPERCHOLESTEROLEMIA; MALE; PYRROLES;

EID: 84863138336     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-011-0818-3     Document Type: Article

References (49)

1. A Corsini FM Maggi AL Catapano 1995 Pharmacology of competitive inhibitors of HMG-CoA reductase Pharmacol Res 31 9 27 7784310 10.1016/1043-6618(95)80042-5 1:CAS:528:DyaK2MXkvFyltbk%3D
2. JL Goldstein MS Brown 1990 Regulation of the mevalonate pathway Nature 343 425 430 10.1038/343425a0 1967820 10.1038/343425a0 1:CAS:528: DyaK3cXhtlCmtbw%3D
3. JG Robinson B Smith N Maheshwari H Schrott 2005 Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis J Am Coll Cardiol 46 1855 1862 10.1016/j.jacc.2005.05.085 16286171 10.1016/j.jacc.2005.05.085 1:CAS:528:DC%2BD2MXht1SrtbzF
4. B Kwak F Mulhaupt S Myit F Mach 2000 Statins as a newly recognized type of immunomodulator Nat Med 6 1399 1402 10.1038/82219 11100127 10.1038/82219 1:CAS:528:DC%2BD3cXosl2hs7k%3D
5. U Schonbeck P Libby 2004 Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents? Circulation 109 II18 II26 10.1161/01.CIR.0000129505.34151.23 15173059 10.1161/01.CIR.0000129505.34151.23
6. G Weitz-Schmidt K Welzenbach V Brinkmann T Kamata J Kallen C Bruns S Cottens Y Takada U Hommel 2001 Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site Nat Med 7 687 692 10.1038/89058 11385505 10.1038/89058 1:CAS:528:DC%2BD3MXktlGkurc%3D
7. L Puccetti AL Pasqui M Pastorelli G Bova M Cercignani A Palazzuoli P Angori A Auteri F Bruni 2002 Time-dependent effect of statins on platelet function in hypercholesterolaemia Eur J Clin Investig 32 901 908 10.1046/j.1365-2362.2002.01086.x 1:CAS:528:DC%2BD3sXkslWisg%3D%3D
8. RP Mason MF Walter RF Jacob 2004 Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress Circulation 109 II34 II41 10.1161/01.CIR.0000129503.62747.03 15173061
9. B Bacova J Radosinska V Knezl L Kolenova P Weismann J Navarova M Barancik M Mitasikova N Tribulova 2010 Omega-3 fatty acids and atorvastatin suppress ventricular fibrillation inducibility in hypertriglyceridemic rat hearts: implication of intracellular coupling protein, connexin-43 J Physiol Pharmacol 61 717 723 21224503 1:CAS:528:DC%2BC3MXitVSrt7g%3D
10. YW Qin P Ye JQ He L Sheng LY Wang J Du 2010 Simvastatin inhibited cardiac hypertrophy and fibrosis in apolipoprotein E-deficient mice fed a "Western-style diet" by increasing PPAR alpha and gamma expression and reducing TC, MMP-9, and Cat S levels Acta Pharmacol Sin 31 1350 1358 10.1038/aps.2010.109 20835264 10.1038/aps.2010.109 1:CAS:528:DC%2BC3cXht1ers77L
11. Y Shen H Wu C Wang H Shao H Huang H Jing D Li 2010 Simvastatin attenuates cardiopulmonary bypass-induced myocardial inflammatory injury in rats by activating peroxisome proliferator-activated receptor gamma Eur J Pharmacol 649 255 262 10.1016/j.ejphar.2010.08.058 20858481 10.1016/j.ejphar.2010.08.058 1:CAS:528:DC%2BC3cXhtlKktb3L
12. SS Arazi FD Genvigir MA Willrich MH Hirata EL Dorea M Bernik RD Hirata 2008 Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response Clin Chim Acta 393 119 124 10.1016/j.cca.2008.03.031 18435918 10.1016/j.cca.2008.03.031 1:CAS:528:DC%2BD1cXmsFKhsrY%3D
13. G Llaverias A Rebollo J Pou M Vazquez-Carrera RM Sanchez JC Laguna M Alegret 2006 Effects of rosiglitazone and atorvastatin on the expression of genes that control cholesterol homeostasis in differentiating monocytes Biochem Pharmacol 71 605 614 10.1016/j.bcp. 2005.11.022 16386711 10.1016/j.bcp.2005.11. 022 1:CAS:528:DC%2BD28XosFKmug%3D%3D
14. V Wibaut-Berlaimont AM Randi V Mandryko MW Lunnon DO Haskard RP Naoumova 2005 Atorvastatin affects leukocyte gene expression in dyslipidemia patients: in vivo regulation of hemostasis, inflammation and apoptosis J Thromb Haemost 3 677 685 10.1111/j.1538-7836.2005.01211.x 15842352 10.1111/j.1538-7836.2005. 01211.x 1:CAS:528:DC%2BD2MXktVOqu7g%3D
15. WM Schmidt AO Spiel B Jilma M Wolzt M Muller 2008 In-vivo effects of simvastatin and rosuvastatin on global gene expression in peripheral blood leucocytes in a human inflammation model Pharmacogenet Genomics 18 109 120 10.1097/FPC.0b013e3282f44d81 18192897 10.1097/FPC.0b013e3282f44d81 1:CAS:528:DC%2BD1cXlsVWgtA%3D%3D
16. G Llaverias J Pou E Ros D Zambon M Cofan A Sanchez M Vazquez-Carrera RM Sanchez JC Laguna M Alegret 2008 Monocyte gene-expression profile in men with familial combined hyperlipidemia and its modification by atorvastatin treatment Pharmacogenomics 9 1035 1054 10.2217/14622416.9.8.1035 18681780 10.2217/14622416.9.8.1035 1:CAS:528:DC%2BD1cXpsFKqs7c%3D
17. RA Irizarry BM Bolstad F Collin LM Cope B Hobbs TP Speed 2003 Summaries of Affymetrix GeneChip probe level data Nucleic Acids Res 31 e15 12582260 10.1093/nar/gng015
18. A Reiner D Yekutieli Y Benjamini 2003 Identifying differentially expressed genes using false discovery rate controlling procedures Bioinformatics 19 368 375 12584122 10.1093/bioinformatics/btf877 1:CAS:528: DC%2BD3sXit1ygt7s%3D
19. V De Re MP Simula L Caggiari N Orzes M Spina A Da Ponte L De Appollonia R Dolcetti V Canzonieri R Cannizzaro 2007 Proteins specifically hyperexpressed in a coeliac disease patient with aberrant T cells Clin Exp Immunol 148 402 409 17335557 10.1111/j.1365-2249.2007.03348.x 10.1111/j.1365-2249.2007.03348.x
20. T Waehre JK Damas L Gullestad AM Holm TR Pedersen KE Arnesen H Torsvik SS Froland AG Semb P Aukrust 2003 Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease J Am Coll Cardiol 41 1460 1467 12742282 10.1016/S0735-1097(03)00263-8 1:CAS:528:DC%2BD3sXksVWju7Y%3D
21. O Grip S Janciauskiene A Bredberg 2008 Use of atorvastatin as an anti-inflammatory treatment in Crohn's disease Br J Pharmacol 155 1085 1092 10.1038/bjp.2008.369 18806816 10.1038/bjp.2008.369 1:CAS:528:DC%2BD1cXhsVWhu7rN
22. J Ma AA Dempsey D Stamatiou KW Marshall CC Liew 2007 Identifying leukocyte gene expression patterns associated with plasma lipid levels in human subjects Atherosclerosis 191 63 72 10.1016/j.atherosclerosis.2006.05.032 16806233 10.1016/j.atherosclerosis.2006.05.032 1:CAS:528:DC%2BD2sXhvVGntr0%3D
23. MS Bretscher S Munro 1993 Cholesterol and the Golgi apparatus Science 261 1280 1281 8362242 10.1126/science.8362242 1:CAS:528:DyaK3sXms1Clu78%3D
24. T Hatano S Kubo S Imai M Maeda K Ishikawa Y Mizuno N Hattori 2007 Leucine-rich repeat kinase 2 associates with lipid rafts Hum Mol Genet 16 678 690 10.1093/hmg/ddm013 17341485 10.1093/hmg/ddm013 1:CAS:528: DC%2BD2sXktlWjsrs%3D
25. K Simons E Ikonen 2000 How cells handle cholesterol Science 290 1721 1726 11099405 10.1126/science.290.5497.1721 1:CAS:528:DC%2BD3cXovVOitbc%3D
26. S Sen-Banerjee S Mir Z Lin A Hamik GB Atkins H Das P Banerjee A Kumar MK Jain 2005 Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells Circulation 112 720 726 10.1161/CIRCULATIONAHA.104.525774 16043642 10.1161/CIRCULATIONAHA.104.525774 1:CAS:528:DC%2BD2MXmsV2jt7w%3D
27. TT Tuomisto H Lumivuori E Kansanen SK Hakkinen MP Turunen JV van Thienen AJ Horrevoets AL Levonen S Yla-Herttuala 2008 Simvastatin has an anti-inflammatory effect on macrophages via upregulation of an atheroprotective transcription factor, Kruppel-like factor 2 Cardiovasc Res 78 175 184 10.1093/cvr/cvn007 18192240 10.1093/cvr/cvn007 1:CAS:528:DC%2BD1cXltFSnurg%3D
28. PT Brinkkoetter U Gottmann J Schulte FJ van der Woude C Braun BA Yard 2006 Atorvastatin interferes with activation of human CD4(+) T cells via inhibition of small guanosine triphosphatase (GTPase) activity and caspase-independent apoptosis Clin Exp Immunol 146 524 532 10.1111/j.1365-2249. 2006.03217.x 17100774 10.1111/j.1365-2249.2006.03217.x 1:CAS:528: DC%2BD2sXmslKmsw%3D%3D
29. KL Rossman CJ Der J Sondek 2005 GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors Nat Rev Mol Cell Biol 6 167 180 10.1038/nrm1587 15688002 10.1038/nrm1587 1:CAS:528:DC%2BD2MXoslOmtA%3D%3D
30. L Zhang ZG Zhang XS Liu A Hozeska-Solgot M Chopp 2007 The PI3K/Akt pathway mediates the neuroprotective effect of atorvastatin in extending thrombolytic therapy after embolic stroke in the rat Arterioscler Thromb Vasc Biol 27 2470 2475 10.1161/ATVBAHA.107.150748 17717296 10.1161/ATVBAHA.107.150748 1:CAS:528:DC%2BD2sXhtFKitbjJ
31. SC Tyagi S Kumar L Katwa 1997 Differential regulation of extracellular matrix metalloproteinase and tissue inhibitor by heparin and cholesterol in fibroblast cells J Mol Cell Cardiol 29 391 404 10.1006/jmcc.1996.0283 9040053 10.1006/jmcc.1996.0283 1:CAS:528:DyaK2sXhsVWkurc%3D
32. SH Schirmer JO Fledderus AM van der Laan TC van der Pouw-Kraan PD Moerland OL Volger JM Baggen M Bohm JJ Piek AJ Horrevoets, et al. 2009 Suppression of inflammatory signaling in monocytes from patients with coronary artery disease J Mol Cell Cardiol 46 177 185 10.1016/j.yjmcc.2008.10.029 19059264 10.1016/j.yjmcc.2008.10.029 1:CAS:528:DC%2BD1MXntVGlsw%3D%3D
33. JG Kang HJ Sung SI Jawed CL Brenneman YN Rao S Sher FM Facio LG Biesecker AA Quyyumi V Sachdev, et al. 2010 FOS expression in blood as a LDL-independent marker of statin treatment Atherosclerosis 212 567 570 10.1016/j. atherosclerosis.2010.06.023 20619839 10.1016/j.atherosclerosis.2010.06.023 1:CAS:528:DC%2BC3cXht1Ogur%2FN
34. Y Majlesi P Samorapoompichit AW Hauswirth GH Schernthaner M Ghannadan M Baghestanian A Rezaie-Majd R Valenta WR Sperr HJ Buhring, et al. 2003 Cerivastatin and atorvastatin inhibit IL-3-dependent differentiation and IgE-mediated histamine release in human basophils and downmodulate expression of the basophil-activation antigen CD203c/E-NPP3 J Leukoc Biol 73 107 117 12525568 10.1189/jlb.0202075 1:CAS:528:DC%2BD3sXnvVyhsQ%3D%3D
35. JA Denburg JE Silver JS Abrams 1991 Interleukin-5 is a human basophilopoietin: induction of histamine content and basophilic differentiation of HL-60 cells and of peripheral blood basophil-eosinophil progenitors Blood 77 1462 1468 1706953 1:CAS:528:DyaK3MXltlelu7c%3D
36. EY Choi ZY Park EJ Choi HM Oh S Lee SC Choi KM Lee SH Im JS Chun CD Jun 2007 Transcriptional regulation of IL-8 by iron chelator in human epithelial cells is independent from NF-kappaB but involves ERK1/2- and p38 kinase-dependent activation of AP-1 J Cell Biochem 102 1442 1457 10.1002/jcb.21367 17471497 10.1002/jcb.21367 1:CAS:528:DC%2BD2sXhsVeitL7K
37. JP Mishra S Mishra K Gee A Kumar 2005 Differential involvement of calmodulin-dependent protein kinase II-activated AP-1 and c-Jun N-terminal kinase-activated EGR-1 signaling pathways in tumor necrosis factor-alpha and lipopolysaccharide-induced CD44 expression in human monocytic cells J Biol Chem 280 26825 26837 10.1074/jbc.M500244200 15923644 10.1074/jbc.M500244200 1:CAS:528:DC%2BD2MXmt1GgsL0%3D
38. A Aljada H Ghanim P Mohanty T Syed A Bandyopadhyay P Dandona 2004 Glucose intake induces an increase in activator protein 1 and early growth response 1 binding activities, in the expression of tissue factor and matrix metalloproteinase in mononuclear cells, and in plasma tissue factor and matrix metalloproteinase concentrations Am J Clin Nutr 80 51 57 15213027 1:CAS:528:DC%2BD2cXltlKltro%3D
39. JL Schwachtgen P Houston C Campbell V Sukhatme M Braddock 1998 Fluid shear stress activation of egr-1 transcription in cultured human endothelial and epithelial cells is mediated via the extracellular signal-related kinase 1/2 mitogen-activated protein kinase pathway J Clin Investig 101 2540 2549 10.1172/JCI1404 9616225 10.1172/JCI1404 1:CAS:528:DyaK1cXjvVaitb4%3D
40. EM Reiche AM Bonametti JC Voltarelli HK Morimoto MA Watanabe 2007 Genetic polymorphisms in the chemokine and chemokine receptors: impact on clinical course and therapy of the human immunodeficiency virus type 1 infection (HIV-1) Curr Med Chem 14 1325 1334 17504215 10.2174/092986707780597934 1:CAS:528:DC%2BD2sXkvFCntro%3D
41. J Oh T Diaz B Wei H Chang M Noda WG Stetler-Stevenson 2006 TIMP-2 upregulates RECK expression via dephosphorylation of paxillin tyrosine residues 31 and 118 Oncogene 25 4230 4234 10.1038/sj.onc.1209444 16491114 10.1038/sj.onc.1209444 1:CAS:528:DC%2BD28XmvFaisrg%3D
42. J Oh DW Seo T Diaz B Wei Y Ward JM Ray Y Morioka S Shi H Kitayama C Takahashi, et al. 2004 Tissue inhibitors of metalloproteinase 2 inhibits endothelial cell migration through increased expression of RECK Cancer Res 64 9062 9069 10.1158/0008-5472.CAN-04-1981 15604273 10.1158/0008-5472.CAN-04-1981 1:CAS:528:DC%2BD2cXhtVOmsLnL
43. MA Pearson D Reczek A Bretscher PA Karplus 2000 Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain Cell 101 259 270 10847681 10.1016/S0092-8674(00)80836-3 1:CAS:528:DC%2BD3cXjtFSrtL8%3D
44. NT Kam E Albright S Mathur FJ Field 1990 Effect of lovastatin on acyl-CoA: cholesterol O-acyltransferase (ACAT) activity and the basolateral-membrane secretion of newly synthesized lipids by CaCo-2 cells Biochem J 272 427 433 2268271 1:CAS:528:DyaK3MXks1I%3D
45. H Chao M Zhou A McIntosh F Schroeder AB Kier 2003 ACBP and cholesterol differentially alter fatty acyl CoA utilization by microsomal ACAT J Lipid Res 44 72 83 12518025 10.1194/jlr.M200191-JLR200 1:CAS:528:DC%2BD3sXlslOhtA%3D%3D
46. N Ghosh-Choudhury CC Mandal GG Choudhury 2007 Statin-induced Ras activation integrates the phosphatidylinositol 3-kinase signal to Akt and MAPK for bone morphogenetic protein-2 expression in osteoblast differentiation J Biol Chem 282 4983 4993 10.1074/jbc.M606706200 17179158 10.1074/jbc.M606706200 1:CAS:528:DC%2BD2sXhsFKgt7g%3D
47. M Matsumoto D Einhaus ES Gold A Aderem 2004 Simvastatin augments lipopolysaccharide-induced proinflammatory responses in macrophages by differential regulation of the c-Fos and c-Jun transcription factors J Immunol 172 7377 7384 15187114 1:CAS:528:DC%2BD2cXks1ahtbk%3D
48. J Gliemann 1998 Receptors of the low density lipoprotein (LDL) receptor family in man. Multiple functions of the large family members via interaction with complex ligands Biol Chem 379 951 964 9792428 1:CAS:528:DyaK1cXmtFyqsLk%3D
49. RR Yammani S Seetharam NM Dahms B Seetharam 2003 Transcobalamin II receptor interacts with megalin in the renal apical brush border membrane J Membr Biol 193 57 66 10.1007/s00232-002-2007-3 12879166 10.1007/s00232-002-2007- 3 1:CAS:528:DC%2BD3sXkvVequ7w%3D